Cardiac catheterisation and coronary intervention both require catheters to be placed into arteries – engendering risk. In their paper, L. Allen Kindman, Joshua Betcher and …
Rare diseases (RDs) are an important public-health issue and a challenge for the medical community. They are called ‘health orphans’, as a result of being …
Israel has a robust and growing pharmaceutical industry, particularly for biopharmaceuticals and advanced therapeutic medicinal products (ATMP). It is home to one of the largest …
With the growth of mobile devices, healthcare professionals (HCPs) and the general public are accessing and collecting medical information via their smartphones. This increasing demand …
In Russia, most CNS clinical studies have been conducted in MS, epilepsy, AD, stroke, depression and schizophrenia. A number of leading Russian biopharmaceutical companies and …
Over the last decade, the only new treatment for Alzheimer’s to make it to market is memantine (Namenda™). The number of failed drug programs in …
In order to address shortcomings at the discovery stage in oncology studies, PDX has recently emerged as the upcoming technique. Through the PDX model, original …
As the benefits of real-world data become more apparent, so too, do issues around its appropriate collection methodology and reliability. Olivier Ethgen of SERFAN Innovation …
When it comes to emerging regions – where sites and monitors generally have less experience in clinical research than those in North America and Western …
The measure of Romania’s success as a clinical trials destination lies in the rapid evolution of the regulatory framework, which was promptly transposed from EU …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
